Bolivia Medical Device Registration: The Regente Técnico and the Qualifying Professions

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

A Bolivian dossier requires Form 027 to be signed jointly by the legal representative and the technical responsible (regente / responsable técnico). Section 2.1 of the manual lists the professions that may act as technical responsible, covering pharmacy, biomedical engineering, electronic engineering, mechanical engineering and others. GRZAN’s assessment is that the institution binds compliance responsibility to a named natural person, which makes the professional fit of the technical responsible and the continuity of that appointment two ongoing management items in importer selection and post-registration maintenance, rather than a single check performed at submission.

This has a consequence that is easy to overlook at planning stage: the registration is held by a company, but it is attested by an individual. When that individual leaves, retires, changes employer or simply becomes unavailable during a review, the dossier does not become invalid automatically, yet the practical ability to answer for it does. Manufacturers that manage the corporate relationship and ignore the named professional discover the gap at the least convenient moment, typically during a deficiency response or a renewal.

The right response is to treat the technical responsible as part of the registered configuration of the product, alongside the manufacturing sites and the product itself, and to manage changes to that configuration with the same discipline.

2. Legal basis

Regulatory instrumentNumberPublication dateRelevant provisions
Manual para Registro Sanitario de Dispositivos MédicosResolución Ministerial N° 010As per the current version on the AGEMED websiteSection 2.1
Manual para Registro Sanitario de Dispositivos MédicosResolución Ministerial N° 010As per the current version on the AGEMED websiteChapter III
Manual para Registro Sanitario de Dispositivos MédicosResolución Ministerial N° 010As per the current version on the AGEMED websiteSection 2.2.2
Decreto Supremo (establishing AGEMED)Decreto Supremo N° 290521 September 2016Article 2

The provisions operate at different levels. Decreto Supremo N° 2905 establishes AGEMED and defines its competence, which is why the signature requirements imposed by the manual have regulatory force rather than the status of internal guidance. Chapter III of the manual sets out the procedural framework within which the file is examined, section 2.1 defines who may sign as technical responsible, and section 2.2.2 ties the establishment’s own documentation to the same submission. The signature is therefore not a formality attached to the end of the process; it is the point at which a licensed professional assumes professional responsibility for the content of the file.

3. Expert insights

Insight 1: the profession list is an or-relationship, but fit is judged at review. Section 2.1 lists several eligible professions and does not prescribe that a given product must be signed by a given profession. In examination practice, however, a clear mismatch between the professional background and the product category becomes a reason for observation. GRZAN’s working rule is that active devices should preferably be signed by a biomedical or electronic engineering background, while implants and consumables should be signed by a pharmacist or a biomedical background. The rule is not a legal requirement, and it should be applied as risk management rather than as a claim about what the manual says.

Insight 2: a change of technical responsible affects the continuity of a dossier already on file. Because Form 027 is a named signature, a change of technical responsible during examination may require the form to be signed again with an explanation of the change. That constitutes a project-level timing risk rather than a paperwork issue: a submission that is otherwise complete can be held while a new signature and its supporting qualification evidence are arranged. Where the change coincides with a deficiency response window, the two delays compound.

Insight 3: signature responsibility and legal responsibility are directly connected. By signing the dossier, the technical responsible assumes professional responsibility for the accuracy of the information it contains. This explains why competent importers impose their own quality requirements on the material they receive: they are not a passive channel but a co-responsible party with its own exposure. Recognising this changes the nature of the relationship, because the importer’s questions about technical content become a shared quality control rather than an obstacle to be managed.

Insight 4: continuity is best secured by contract, not by goodwill. The manual does not require an importer to notify a manufacturer when its technical responsible changes, so the obligation has to be created privately. A short notice clause, coupled with an obligation to nominate a successor whose qualification covers the registered product categories, converts an unpredictable event into a managed one. Without such a clause the manufacturer learns of the change when a procedure stalls, which is precisely when it can least afford to.

4. Practical recommendations

  1. Verify the professional qualification of the technical responsible and its fit with the product category during importer diligence.
  2. Include an advance notice obligation for any change of technical responsible in the distribution agreement, together with a requirement that the successor’s qualification covers the registered categories.
  3. Treat the importer as a co-responsible party rather than a filing agent, and provide the complete technical documentation rather than the minimum usable set.
  4. Keep the qualification evidence of the named professional on file, so that a change of signatory can be supported with documentation rather than assertion.

5. Verification checklist

  • □ Form 027 has been signed by the technical responsible
  • □ The profession of the technical responsible falls within the list in section 2.1
  • □ The professional background matches the target product category
  • □ The distribution agreement provides for notification of a change of technical responsible
  • □ The technical responsible is within the valid term of the appointment

Regulatory information verified as of October 29, 2026.

GRZAN supports medical device manufacturers, importers and authorised representatives with registration in Bolivia, including verification of the technical responsible requirement under section 2.1 of Resolución Ministerial N° 010, review of the signature and qualification chain behind Form 027, and the drafting of notice and succession clauses that keep a registration usable through changes of personnel. For assistance with a specific product or importer arrangement in Bolivia, contact the GRZAN regulatory team at info@grzanglobal.com.

GRZAN applies a writing standard of conclusions first, traceable sources and verifiable figures to its regulatory publications, and follows the practice of AGEMED and the authorities cited in this series as it develops. For a market access plan covering the technical, contractual and personnel dimensions of a Bolivian registration, the team welcomes your enquiry.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail